Concepedia

The EORTC Tables Overestimate the Risk of Recurrence and Progression in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: External Validation of the EORTC Risk Tables

J.M. Fernández Gómez, Rosário Madero, Eduardo Solsona, Miguel Unda, Luis Martínez‐Piñeiro, Antonio Ojea, José Portillo, Manuel Sierra Montesinos, C Pertusa, Jesús Rodríguez-Molina,

European Urology · 2011 · 166 citations · 9 references

DOIFull text

Open access

Concepts

References

9

Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

Richard Sylvester, Adrian P.M. van der Meijden, Willem Oosterlinck et al. · European Urology · 2006 · 3K citations

, , +10

Prognosis and prognostic research: validating a prognostic model

Doug Altman, Yvonne Vergouwe, Patrick Royston et al. · BMJ · 2009 · 1.5K citations

, , +12

What do we mean by validating a prognostic model?

Douglas G. Altman, Patrick Royston · Statistics in Medicine · 2000 · 1.4K citations

, , +12

Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model

J.M. Fernández Gómez, Rosário Madero, Eduardo Solsona et al. · The Journal of Urology · 2009 · 655 citations · Full text

, , +9

Prognostic Factors in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Multivariate Analysis of Data from Four Randomized CUETO Trials

J.M. Fernández Gómez, Eduardo Solsona, Miguel Unda et al. · European Urology · 2007 · 257 citations · Full text

, , +6